Compare AANJANEYA LIFECARE with SUVEN LIFE - Equitymaster

Helping You Build Wealth With Honest Research
Since 1996. Try Now

  • MyStocks

MEMBER'S LOGINX

     
Login Failure
   
     
   
     
 
 
 
(Please do not use this option on a public machine)
 
     
 
 
 
  Sign Up | Forgot Password?  

DR. DATSONS LABS vs SUVEN LIFESCIENCES - Comparison Results

DO YOU LIKE THESE REPORTS? TELL US!

Current Valuations

    DR. DATSONS LABS SUVEN LIFESCIENCES DR. DATSONS LABS/
SUVEN LIFESCIENCES
 
P/E (TTM) x -10.9 19.8 - View Chart
P/BV x 0.2 4.0 4.0% View Chart
Dividend Yield % 0.0 0.5 -  

Financials

 DR. DATSONS LABS   SUVEN LIFESCIENCES
EQUITY SHARE DATA
    DR. DATSONS LABS
Mar-14
SUVEN LIFESCIENCES
Mar-19
DR. DATSONS LABS/
SUVEN LIFESCIENCES
5-Yr Chart
Click to enlarge
High Rs126338 37.2%   
Low Rs31169 18.2%   
Sales per share (Unadj.) Rs133.052.1 255.1%  
Earnings per share (Unadj.) Rs0.26.8 2.2%  
Cash flow per share (Unadj.) Rs6.68.6 77.1%  
Dividends per share (Unadj.) Rs01.50 0.0%  
Dividend yield (eoy) %00.6 0.0%  
Book value per share (Unadj.) Rs128.865.3 197.3%  
Shares outstanding (eoy) m31.66127.28 24.9%   
Bonus/Rights/Conversions FCCB--  
Price / Sales ratio x0.64.9 12.1%   
Avg P/E ratio x516.137.1 1,390.4%  
P/CF ratio (eoy) x11.829.6 40.0%  
Price / Book Value ratio x0.63.9 15.6%  
Dividend payout %022.0 0.0%   
Avg Mkt Cap Rs m2,47732,272 7.7%   
No. of employees `000NA1.1 0.0%   
Total wages/salary Rs m56661 8.5%   
Avg. sales/employee Rs ThNM6,132.2-  
Avg. wages/employee Rs ThNM611.1-  
Avg. net profit/employee Rs ThNM803.5-  
INCOME DATA
Net Sales Rs m4,2116,635 63.5%  
Other income Rs m79242 32.5%   
Total revenues Rs m4,2896,877 62.4%   
Gross profit Rs m5691,604 35.4%  
Depreciation Rs m204221 92.3%   
Interest Rs m43038 1,141.1%   
Profit before tax Rs m131,587 0.8%   
Minority Interest Rs m00-   
Prior Period Items Rs m-20-   
Extraordinary Inc (Exp) Rs m00-   
Tax Rs m6718 0.8%   
Profit after tax Rs m5869 0.6%  
Gross profit margin %13.524.2 55.9%  
Effective tax rate %48.045.2 106.2%   
Net profit margin %0.113.1 0.9%  
BALANCE SHEET DATA
Current assets Rs m6,8526,232 109.9%   
Current liabilities Rs m6,7111,490 450.3%   
Net working cap to sales %3.371.5 4.7%  
Current ratio x1.04.2 24.4%  
Inventory Days Days16186 186.1%  
Debtors Days Days31883 385.6%  
Net fixed assets Rs m3,6734,043 90.8%   
Share capital Rs m317127 248.7%   
"Free" reserves Rs m3,7618,183 46.0%   
Net worth Rs m4,0788,310 49.1%   
Long term debt Rs m1,67118 9,386.5%   
Total assets Rs m12,63310,389 121.6%  
Interest coverage x1.043.1 2.4%   
Debt to equity ratio x0.40 19,129.6%  
Sales to assets ratio x0.30.6 52.2%   
Return on assets %3.48.7 39.4%  
Return on equity %0.110.5 1.1%  
Return on capital %7.719.5 39.3%  
Exports to sales %22.90-   
Imports to sales %14.30-   
Exports (fob) Rs m964NA-   
Imports (cif) Rs m602NA-   
Fx inflow Rs m9645,622 17.1%   
Fx outflow Rs m6071,799 33.7%   
Net fx Rs m3573,822 9.3%   
CASH FLOW
From Operations Rs m1,345356 378.3%  
From Investments Rs m-2,256-279 809.6%  
From Financial Activity Rs m-1,200-225 533.0%  
Net Cashflow Rs m-2,111-148 1,424.2%  

Share Holding

Indian Promoters % 4.5 63.4 7.1%  
Foreign collaborators % 0.0 0.0 -  
Indian inst/Mut Fund % 0.0 0.0 -  
FIIs % 1.4 0.0 -  
ADR/GDR % 0.0 0.0 -  
Free float % 94.1 36.5 257.8%  
Shareholders   20,807 37,287 55.8%  
Pledged promoter(s) holding % 0.0 0.0 -  
NM: Not Meaningful
Source: Company Annual Reports, Regulatory Filings, Equitymaster

Compare DR. DATSONS LABS With:   ASTRAZENECA PHARMA  ALEMBIC PHARMA  CADILA HEALTHCARE  NOVARTIS  PANACEA BIOTECH  

Compare DR. DATSONS LABS With:   MYLAN (US)  ADCOCK INGRAM (S. Africa)  ACTAVIS (US)  TEVA PHARMA (Israel)  



Today's Market

Sensex Opens Flat; Sun Pharma and ITC Top Losers(09:30 am)

Asian stock markets are mixed today. The Nikkei 225 is flat while the Hang Seng is down 0.3%. The Shanghai Composite is trading up by 0.1%.

Related Views on News

SUVEN LIFESCIENCES Announces Quarterly Results (1QFY20); Net Profit Up 47.2% (Quarterly Result Update)

Aug 28, 2019 | Updated on Aug 28, 2019

For the quarter ended June 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 572 m (up 47.2% YoY). Sales on the other hand came in at Rs 2 bn (up 3.8% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFESCIENCES 2018-19 Annual Report Analysis (Annual Result Update)

Jul 22, 2019 | Updated on Jul 22, 2019

Here's an analysis of the annual report of SUVEN LIFESCIENCES for 2018-19. It includes a full income statement, balance sheet and cash flow analysis of SUVEN LIFESCIENCES. Also includes updates on the valuation of SUVEN LIFESCIENCES.

MSTC IPO: Should You Bet on This State-Run E-Commerce Player? (IPO)

Mar 13, 2019

Should you subscribe to the IPO of MSPC Limited?

SUVEN LIFESCIENCES Announces Quarterly Results (4QFY19); Net Profit Up 8.7% (Quarterly Result Update)

May 27, 2019 | Updated on May 27, 2019

For the quarter ended March 2019, SUVEN LIFESCIENCES has posted a net profit of Rs 680 m (up 8.7% YoY). Sales on the other hand came in at Rs 3 bn (up 18.5% YoY). Read on for a complete analysis of SUVEN LIFESCIENCES's quarterly results.

SUVEN LIFE Announces Quarterly Results (3QFY19); Net Profit Down 27.1% (Quarterly Result Update)

Feb 13, 2019 | Updated on Feb 13, 2019

For the quarter ended December 2018, SUVEN LIFE has posted a net profit of Rs 252 m (down 27.1% YoY). Sales on the other hand came in at Rs 1 bn (down 21.2% YoY). Read on for a complete analysis of SUVEN LIFE's quarterly results.

More Views on News

Most Popular

Use My Secret to Increase Your Trading Profits Today

Dec 10, 2019

What to do after every trade.

How We Made 14.64% Trading Profit in Just 2 Days

Dec 12, 2019

A high probability trade that worked to perfection for my subscribers.

Blue Chips Are Passe. Get into these Stocks for Outstanding Gains in 2020(Profit Hunter)

Dec 5, 2019

This corner of the market could provide more returns than blue chips in 2020.

Make the Most of the Smallcap Rebound with These Stocks(Profit Hunter)

Dec 3, 2019

Even amid a gloomy economic scenario, there are smallcaps that have grown earnings over last one and a half year and I believe these could be the strongest candidates for a smallcap rebound.

Stocks that Can Outperform No Matter what the RBI Does Today(The 5 Minute Wrapup)

Dec 5, 2019

I won't be surprised if these stocks repeat their 2002-2006 performance.

More

Get the Indian Stock Market's
Most Profitable Ideas

How To Beat Sensex Guide 2020
Get our special report, How to Beat Sensex Nearly 3X Now!
We will never sell or rent your email id.
Please read our Terms

DR. DATSONS LABS SHARE PRICE


May 21, 2015 (Close)

TRACK DR. DATSONS LABS

  • Track your investment in DR. DATSONS LABS with Equitymaster's Portfolio Tracker. Set live price alerts, get research alerts and more. Get access now...
  • Add To MyStocks

MORE ON DR. DATSONS LABS

DR. DATSONS LABS - AJANTA PHARMA COMPARISON

COMPARE DR. DATSONS LABS WITH

MARKET STATS